A 36-year-old Brazilian man made headlines around the world in 2020 for being the first person to be putatively cured of human immunodeficiency virus (HIV) using an easily accessible and ...

As a part of its life cycle, the human immunodeficiency virus-1 (HIV) inserts a copy of its DNA into human immune cells. Some of these newly infected immune cells can then transition into a dormant, ...

We might be a step closer to curing HIV, as researchers have developed a way to knock out a version of the virus lurking in the body. Using something called an HIV-like particle (HLP)—which are dead ...

In the study published in the journal Emerging Microbes and Infections, the team demonstrated that the patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...

An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction ...

Before any treatment, each clinician and patient must determine whether the anticipated benefits outweigh the potential toll caused on the body. Study results published in Nature suggest that latent ...

A research team led by Professor Chu Hin (first right) and Professor Chen Zhiwei (first left) has discovered that inhibiting the BRD9 protein can effectively reactivate latent HIV-1. When used in ...

It is not an exaggeration to say that the development of antiretroviral therapy is one of the most significant accomplishments in the history of medicine. In the early days of the HIV pandemic, newly ...

Stephen Kent receives funding from the NHMRC, the MRFF, the ARC and the NIH. Chan Phetsouphanh receives funding from NHMRC and MRFF. University of Melbourne provides funding as a founding partner of ...